196 related articles for article (PubMed ID: 25818660)
1. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
Tagliaferri E; Menichetti F
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
[TBL] [Abstract][Full Text] [Related]
2. Invasive candidiasis.
Lass-Flörl C; Kanj SS; Govender NP; Thompson GR; Ostrosky-Zeichner L; Govrins MA
Nat Rev Dis Primers; 2024 Mar; 10(1):20. PubMed ID: 38514673
[TBL] [Abstract][Full Text] [Related]
3. What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.
Bassetti M; Righi E; Montravers P; Cornely OA
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i14-i25. PubMed ID: 29304208
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation.
Zilberberg MD; Kothari S; Shorr AF
Crit Care; 2009; 13(3):R94. PubMed ID: 19545361
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of Rezafungin: the latest treatment option for adults with candidemia and invasive candidiasis.
Sharma D; Vazquez JA
Expert Opin Pharmacother; 2024 Mar; 25(4):339-347. PubMed ID: 38497379
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of invasive neonatal candidiasis.
Botero-Calderon L; Benjamin DK; Cohen-Wolkowiez M
Expert Opin Pharmacother; 2015 May; 16(7):1035-48. PubMed ID: 25842986
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole prophylaxis for prevention of invasive candidiasis in infants.
Ericson JE; Benjamin DK
Curr Opin Pediatr; 2014 Apr; 26(2):151-6. PubMed ID: 24626156
[TBL] [Abstract][Full Text] [Related]
8. Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.
Yeoh SF; Lee TJ; Chew KL; Lin S; Yeo D; Setia S
Infect Drug Resist; 2018; 11():805-819. PubMed ID: 29881298
[No Abstract] [Full Text] [Related]
9. Regulatory Considerations in the Approval of Rezafungin (REZZAYO) for the Treatment of Candidemia and Invasive Candidiasis in Adults.
Smith HL; Bensman TJ; Mishra S; Li X; Dixon CA; Sheikh J; McMaster OG; Joshi A; Rubin DB; Goodwin A; Miller TJ; Danielsen ZY; Syed I; Shukla SJ; Iarikov D; Kim PW; Farley JJ
J Infect Dis; 2024 Mar; ():. PubMed ID: 38502709
[TBL] [Abstract][Full Text] [Related]
10. Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.
Miyazaki T; Kohno S
Expert Rev Anti Infect Ther; 2015; 13(9):1171-83. PubMed ID: 26089168
[TBL] [Abstract][Full Text] [Related]
11. Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.
Eschenauer GA; Nguyen MH; Clancy CJ
Ann Pharmacother; 2015 Sep; 49(9):1068-74. PubMed ID: 26104051
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the predictive indices for candidemia in an adult intensive care unit.
Gaspar GG; Menegueti MG; Auxiliadora-Martins M; Basile-Filho A; Martinez R
Rev Soc Bras Med Trop; 2015; 48(1):77-82. PubMed ID: 25860468
[TBL] [Abstract][Full Text] [Related]
13. Antifungal drug resistance among Candida species: mechanisms and clinical impact.
Sanguinetti M; Posteraro B; Lass-Flörl C
Mycoses; 2015 Jun; 58 Suppl 2():2-13. PubMed ID: 26033251
[TBL] [Abstract][Full Text] [Related]
14. Clinical and therapeutic aspects of candidemia: a five year single centre study.
Bassetti M; Merelli M; Ansaldi F; de Florentiis D; Sartor A; Scarparo C; Callegari A; Righi E
PLoS One; 2015; 10(5):e0127534. PubMed ID: 26010361
[TBL] [Abstract][Full Text] [Related]
15. Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.
Ferreira D; Grenouillet F; Blasco G; Samain E; Hénon T; Dussaucy A; Millon L; Mercier M; Pili-Floury S
Intensive Care Med; 2015 Jun; 41(6):1077-88. PubMed ID: 25894623
[TBL] [Abstract][Full Text] [Related]
16. Candidemia and invasive candidiasis in adults: A narrative review.
Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
[TBL] [Abstract][Full Text] [Related]
17. The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected].
De Rosa FG; Corcione S; Filippini C; Raviolo S; Fossati L; Montrucchio C; Aldieri C; Petrolo A; Cavallo R; Di Perri G
PLoS One; 2015; 10(5):e0125149. PubMed ID: 25938486
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan.
Mikamo H; Matsumizu M; Nakazuru Y; Okayama A; Nagashima M
J Infect Chemother; 2015 Jul; 21(7):520-6. PubMed ID: 25887336
[TBL] [Abstract][Full Text] [Related]
19. Invasive candidiasis in non neutropenic critically ill - need for region-specific management guidelines.
Ahmed A; Azim A; Baronia AK; Marak RS; Gurjar M
Indian J Crit Care Med; 2015 Jun; 19(6):333-9. PubMed ID: 26195859
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.
Ou HT; Lee TY; Chen YC; Charbonneau C
BMC Infect Dis; 2017 Jul; 17(1):481. PubMed ID: 28693479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
